CA
NZ
UK
AU
IND
US
The financial technology company offers low-cost banking and payments products, with deposits insured through partner banks. MyPay origination volume hit a record USD 5.3 billion with loss rates around 1%, annualized revenue above USD 500 million and record transaction profit of USD 80 million. …
Key HighlightsVeracyte, Inc. (NASDAQ:VCYT) fell 54.9% and MNTN fell 54% after results released on November 4, 2026, both tied to lower guidance rather than a collapse in the reported quarter.BuzzFeed, Inc. (NASDAQ:BZFD) fell 38% after third quarterRevenuedropped 44% to USD 26.0 million and management …
Key HighlightsNet income was USD 3.9 million for the third quarter of 2026, versus a net loss of USD 8.8 million a year earlier, after a USD 6.3 million loss from operations.Fair value gains of USD 7.5 million onWarrantliabilities and USD 3.4 million on …
Key HighlightsLakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) was quoted 290.33% higher after retiring all Series C preferred stock for USD 1,270,970, a nano-cap move on about 45 times normal volume.Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.68% on 44%Revenuegrowth to USD 107.2 million, raised 2026 guidance and …
Adjusted SG&A (non-GAAP) rose 60.1% to USD 113.8 million, or 15.0% of revenue against 14.3%. The company, which uses its Clover Assistant software to support physician care ofMedicareAdvantage members, said its flagship PPO, about 98% of current membership, received a 5 Star rating for …
Key HighlightsVeracyte, Inc. (NASDAQ:VCYT) fell 54.9% to USD 23.69 after lowering 2026 testingRevenueguidance, even though third quarter revenue rose 15% to USD 151.8 million.Akebia Therapeutics (NASDAQ:AKBA) fell 33.91% to USD 0.4591 after third quarter revenue dropped to USD 36.9 million from USD 58.8 million …
For nine months, revenues were USD 117.2 million against USD 116.1 million, income from operations was USD 23.7 million versus a loss of USD 3.9 million, and net loss was USD 23.3 million. The improvement mostly reflects the absence of the 2025 impairment charge, …
Key HighlightsLakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) rose 290.33% onVolumenear 45 times normal, while Antelope rose 78.63% on volume near 47 times normal, the heaviest turnover relative to history in this group.Zeta Network Group (NASDAQ:ZNB) rose 73.7% on an unconfirmed AI infrastructure theme, with cash of …
Key HighlightsNet income was USD 23.6 million in the third quarter of 2026 against a net loss of USD 87.2 million, with USD 21.5 million attributable to Holdings, or USD 0.06 per common share.Pre-tax income from continuing operations was only USD 3.1 million, so …
Key HighlightsAdagio Medical Holdings (NASDAQ:ADGM) fell 29.93% a day after announcing a 1-for-30 reverse split effective November 6, 2026, while CL Workshop fell 26.49% before an ADS ratio change equal to 1-for-80.NewGenIvf Group Limited (NASDAQ:NIVF) fell 26.05% to USD 0.5121 after a 1-for-8 reverse …
Please wait processing your request...